T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs

European Journal of Immunology

Volumn 45, Issue 11, 2015, Pages 3140-3149

  Burchill, Matthew A ^a,b   Tamburini, Beth A ^a   Kedl, Ross M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

CD27; CD70; CD8 T cell; Competition; Dendritic cell

Indexed keywords

APC PROTEIN; CD27 ANTIGEN; CD70 ANTIGEN; LIGAND; NEUTROPHIL COLLAGENASE;

ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL SURFACE; CELL SURVIVAL; CONFOCAL MICROSCOPY; DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; COCULTURE; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD27; ANTIGENS, CD70; COCULTURE TECHNIQUES; DENDRITIC CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 84951570153     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545749     Document Type: Article

References (45)

1. + T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J. Exp. Med. 2009. 206: 435-448.
2. Moon, J. J., Chu, H. H., Pepper, M., McSorley, S. J., Jameson, S. C., Kedl, R. M. and Jenkins, M. K., Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007. 27: 203-213.
3. McHeyzer-Williams, M. G. and Davis, M. M., Antigen-specific development of primary and memory T cells in vivo. Science 1995. 268: 106-111.
4. Marrack, P., Mitchell, T., Hildeman, D., Kedl, R., Teague, T. K., Bender, J., Rees, W. et al., Genomic-scale analysis of gene expression in resting and activated T cells. Curr. Opin. Immunol. 2000. 12: 206-209.
5. Kedl, R. M., Kappler, J. W. and Marrack, P., Epitope dominance, competition and T cell affinity maturation. Curr. Opin. Immunol. 2003. 15: 120-127.
6. Kedl, R. M., Rees, W. A., Hildeman, D. A., Schaefer, B., Mitchell, T., Kappler, J. and Marrack, P., T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 2000. 192: 1105-1113.
7. Kedl, R. M., Schaefer, B. C., Kappler, J. W. and Marrack, P., T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat. Immunol. 2002. 3: 27-32.
8. Huang, J. F., Yang, Y., Sepulveda, H., Shi, W., Hwang, I., Peterson, P. A., Jackson, M. R. et al., TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 1999. 286: 952-954.
9. Hwang, I., Huang, J. F., Kishimoto, H., Brunmark, A., Peterson, P. A., Jackson, M. R., Surh, C. D. et al., T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 2000. 191: 1137-1148.
10. Kedl, R. M., Rees, W. A., Hildeman, D. A., Schaefer, B., Mitchell, T., Kappler, J. and Marrack, P., T Cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 2000. 192: 1105-1114.
11. Willis, R. A., Kappler, J. W. and Marrack, P. C., CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc. Natl. Acad. Sci. USA 2006. 103: 12063-12068.
12. Tesselaar, K., Gravestein, L. A., van Schijndel, G. M., Borst, J. and van Lier, R. A., Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 1997. 159: 4959-4965.
13. Hintzen, R. Q., Lens, S. M., Lammers, K., Kuiper, H., Beckmann, M. P. and van Lier, R. A., Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 1995. 154: 2612-2623.
14. Hendriks, J., Xiao, Y. and Borst, J., CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 2003. 198: 1369-1380.
15. + T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling. Vaccine 2012. 30: 1154-1161.
16. van Gisbergen, K. P., Klarenbeek, P. L., Kragten, N. A., Unger, P. P., Nieuwenhuis, M. B., Wensveen, F. M., ten Brinke, A. et al., The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variants. Immunity 2011. 35: 97-108.
17. + T cell expansion with variable dependence on type I IFN. J. Exp. Med. 2004. 199: 775-784.
18. Kurche, J. S., Burchill, M. A., Sanchez, P. J., Haluszczak, C. and Kedl, R. M., Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses. J. Immunol. 2010. 185: 2106-2115.
19. Sanchez, P. J., McWilliams, J. A., Haluszczak, C., Yagita, H. and Kedl, R. M., Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J. Immunol. 2007. 178: 1564-1572.
20. Edwards, L. E., Haluszczak, C. and Kedl, R. M., Phenotype and function of protective, CD4-independent CD8 T cell memory. Immunol. Res. 2013. 55: 135-145.
21. Kuka, M., Munitic, I., Giardino Torchia, M. L. and Ashwell, J. D., CD70 is downregulated by interaction with CD27. J. Immunol. 2013. 191: 2282-2289.
22. Widney, D., Gundapp, G., Said, J. W., van der Meijden, M., Bonavida, B., Demidem, A., Trevisan, C. et al., Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin. Immunol. 1999. 93: 114-123.
23. Yalcin, B., Canpinar, H., Kutluk, M. T., Varan, A., Akyuz, C. and Buyukpamukcu, M., Cerebrospinal fluid soluble CD27 levels in children with non-Hodgkin lymphomas. Pediatr. Hematol. Oncol. 2004. 21: 717-723.
24. Kara, I. O., Sahin, B. and Gunesacar, R., Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis. Adv. Ther. 2007. 24: 29-40.
25. Kara, I. O., Sahin, B. and Gunesacar, R., Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies. Adv. Ther. 2007. 24: 741-747.
26. Gattorno, M., Prigione, I., Vignola, S., Falcini, F., Chiesa, S., Morandi, F., Picco, P. et al., Levels of soluble CD27 in sera and synovial fluid and its expression on memory T cells in patients with juvenile idiopathic arthritides. Clin. Exp. Rheumatol. 2002. 20: 863-866.
27. Loenen, W. A., De Vries, E., Gravestein, L. A., Hintzen, R. Q., Van Lier, R. A. and Borst, J., The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur. J. Immunol. 1992. 22: 447-455.
28. Kato, K., Chu, P., Takahashi, S., Hamada, H. and Kipps, T. J., Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Exp. Hematol. 2007. 35: 434-442.
29. Zhou, Y., Liu, X., Xu, L., Tseng, H., Cao, Y., Jiang, J., Ciccarelli, B. T. et al., Matrix metalloproteinase-8 is overexpressed in Waldenstrom's macroglobulinemia cells, and specific inhibition of this metalloproteinase blocks release of soluble CD27. Clin. Lymphoma. Myeloma. Leuk. 2011. 11: 172-175.
30. + T cell lineage commitment. Nat. Immunol. 2005. 6: 793-799.
31. Zehn, D., Lee, S. Y. and Bevan, M. J., Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009. 458: 211-214.
32. Burchill, M. A., Tamburini, B. A., Pennock, N. D., White, J. T., Kurche, J. S. and Kedl, R. M., T cell vaccinology: exploring the known unknowns. Vaccine 2013. 31: 297-305.
33. Huang, J., Jochems, C., Anderson, A. M., Talaie, T., Jales, A., Madan, R. A., Hodge, J. W. et al., Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J. Immunol. 2013. 190: 6250-6258.
34. Font, J., Pallares, L., Martorell, J., Martinez, E., Gaya, A., Vives, J. and Ingelmo, M., Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1996. 81: 239-243.
35. Huang, J., Jochems, C., Talaie, T., Anderson, A., Jales, A., Tsang, K. Y., Madan, R. A. et al., Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood 2012. 120: 3030-3038.
36. Kalayjian, R. C., Machekano, R. N., Rizk, N., Robbins, G. K., Gandhi, R. T., Rodriguez, B. A., Pollard, R. B. et al., Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J. Infect. Dis. 2010. 201: 1796-1805.
37. Swaak, A. J., Hintzen, R. Q., Huysen, V., van den Brink, H. G. and Smeenk, J. T., Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course. Clin. Rheumatol. 1995. 14: 293-300.
38. + T cell tolerance and permits effective immunity. Immunity 2008. 29: 934-946.
39. + T-cell immunity by immature dendritic cells in a vaccination setting. Blood 2009. 113: 5167-5175.
40. Arens, R., Tesselaar, K., Baars, P. A., van Schijndel, G. M., Hendriks, J., Pals, S. T., Krimpenfort, P. et al., Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001. 15: 801-812.
41. Beishuizen, C. R., Kragten, N. A., Boon, L., Nolte, M. A., van Lier, R. A. and van Gisbergen, K. P., Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions. J. Immunol. 2009. 183: 6442-6451.
42. He, L. Z., Prostak, N., Thomas, L. J., Vitale, L., Weidlick, J., Crocker, A., Pilsmaker, C. D. et al., Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice. J. Immunol. 2013. 191: 4174-4183.
43. Thomas, L. J., He, L. Z., Marsh, H. and Keler, T., Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity. Oncoimmunology 2014. 3: e27255.
44. Vitale, L. A., He, L. Z., Thomas, L. J., Widger, J., Weidlick, J., Crocker, A., O'Neill, T. et al., Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemia. Clin. Cancer Res. 2012. 18: 3812-3821.
45. Tamburini, B. A., Burchill, M. A. and Kedl, R. M., Antigen capture and archiving by lymphatic endothelial cells following vaccination or viral infection. Nat. Commun. 2014. 5: 3989.